Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

7.83USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$7.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,814
52-wk High
$31.72
52-wk Low
$6.30

ORMP.OQ

Chart for ORMP.OQ

About

Oramed Pharmaceuticals Inc. is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for... (more)

Overall

Beta: 0.20
Market Cap (Mil.): $77.96
Shares Outstanding (Mil.): 9.96
Dividend: --
Yield (%): --

Financials

  ORMP.OQ Industry Sector
P/E (TTM): -- 152.31 33.65
EPS (TTM): -0.55 -- --
ROI: -36.80 -1.40 17.48
ROE: -37.18 -6.49 18.31
Search Stocks

Oramed's oral insulin succeeds in study, shares jump

- Oramed Pharmaceuticals Inc said its oral insulin capsule appeared to be safe and was well-tolerated by diabetics in a mid-stage trial.

22 Oct 2014

Oramed's oral insulin succeeds in study, shares jump

Oct 22 - Oramed Pharmaceuticals Inc said its oral insulin capsule appeared to be safe and was well-tolerated by diabetics in a mid-stage trial.

22 Oct 2014

Earnings vs. Estimates

Search Stocks